Literature DB >> 17947825

Ocular biometry in acute and chronic angle-closure glaucoma.

Yu-Wen Lan1, Jui-Wen Hsieh, Por-Tying Hung.   

Abstract

AIM: To evaluate the biometric difference between eyes with acute angle-closure (AAC) attack, their uninvolved fellow eyes and eyes with chronic angle-closure glaucoma (CACG).
METHODS: Patients with prior laser iridotomy on both eyes for unilateral AAC attack or CACG were recruited. We compared ocular biometric parameters by A-scan ultrasonography of the acutely affected eyes with those of the uninvolved fellow eyes and with eyes affected by CACG.
RESULTS: Thirty-three patients with unilateral AAC attack and 41 patients with CACG were included. The eyes with AAC attack had a significantly shallower anterior chamber depth (ACD), thicker lens, shorter axial length, higher lens/axial length factor and more anteriorly positioned lens than the eyes with CACG. The uninvolved fellow eyes had a significantly shallower ACD, shorter axial length and higher lens/axial length factor compared with the eyes with CACG. Acutely affected eyes had a shallower ACD and more anteriorly positioned lens than did the uninvolved fellow eyes.
CONCLUSION: Eyes with AAC attack had a more crowded anterior segment compared with uninvolved fellow eyes and those affected by CACG. In addition to ACD, relative lens size, represented by the lens/axial length factor, and relative lens position appear to play important roles in the development of AAC attack. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17947825     DOI: 10.1159/000107498

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  16 in total

1.  The biometric study in different stages of primary angle-closure glaucoma.

Authors:  Y-Y Chen; Y-Y Chen; S-J Sheu; P Chou
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

2.  Factors affecting refractive outcome after cataract surgery in patients with a history of acute primary angle closure.

Authors:  Hyo Seok Lee; Jung Won Park; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2013-10-29       Impact factor: 2.447

3.  Role of lens vault in subtypes of angle closure in Iranian subjects.

Authors:  S Moghimi; Z Vahedian; N Zandvakil; M Mohammdi; G Fakhraie; N Nassiri; A L Coleman; S Lin
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

4.  Distribution and analysis of intraocular pressure and its possible association with glaucoma in children.

Authors:  Fang Han; Jun Li; Xinheng Zhao; Xiaoliang Li; Pinghui Wei; Yan Wang
Journal:  Int Ophthalmol       Date:  2021-04-11       Impact factor: 2.031

5.  Relationship between relative lens position and appositional closure in eyes with narrow angles.

Authors:  Yasumasa Otori; Yuki Tomita; Ayumi Hamamoto; Kanae Fukui; Shinichi Usui; Misako Tatebayashi
Journal:  Jpn J Ophthalmol       Date:  2011-03-13       Impact factor: 2.447

6.  Relationship between ocular biometry and severity of primary angle-closure glaucoma: relevance for predictive, preventive, and personalized medicine.

Authors:  Shengjie Li; Mingxi Shao; Yani Wan; Binghua Tang; Xinghuai Sun; Wenjun Cao
Journal:  EPMA J       Date:  2019-06-11       Impact factor: 6.543

7.  Ocular biometry in angle closure.

Authors:  Mohammad Reza Razeghinejad; Mohammad Banifatemi
Journal:  J Ophthalmic Vis Res       Date:  2013-01

8.  Scheimpflug imaging criteria for identifying eyes at high risk of acute angle closure.

Authors:  Mohammad Pakravan; Farideh Sharifipour; Shahin Yazdani; Nasim Koohestani; Mehdi Yaseri
Journal:  J Ophthalmic Vis Res       Date:  2012-04

9.  Primary phacoemulsification and intraocular lens implantation for acute primary angle-closure.

Authors:  Wei-Wen Su; Phil Yeong-Fung Chen; Ching-Hsi Hsiao; Henry Shen-Lih Chen
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

10.  Gonioscopic features in patients with acute and chronic angle-closure glaucoma.

Authors:  Mohammad Reza Razeghinejad
Journal:  Iran J Med Sci       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.